Precision Biosciences Reports Third-Quarter 2026 Results
Revenue was $0 versus $13K a year earlier. Net loss narrowed to $7.6M from $21.8M, including a $12.7M non-cash gain from changes in warrant fair value. Diluted EPS was $(0.28), compared with $(1.84).
Story updates
01:19:36 PM UTC
SquawkNews
Precision BioSciences reported a third-quarter 2026 net loss of $7.6 million, compared with a $21.8 million loss a year earlier, and ended September with $108.0 million in cash, cash equivalents and restricted cash. Operating expenses totaled $20.4 million, while a non-cash gain related to warrant…
Precision Biosciences reported third-quarter 2026 revenue of $0 compared with $13K a year earlier, and a net loss of $7.6M versus $21.8M. The narrower loss included a $12.7M non-cash gain from changes in warrant fair value. Diluted EPS was $(0.28), compared with $(1.84) in the prior-year quarter.Fi…